JFG
Jefferies Financial Group Portfolio holdings
AUM
$12.2B
1-Year Est. Return
38.49%
This Fund
S&P 500
1 Year Est. Return
+38.49%
AUM
$12.2B
AUM Growth
+$1.3B
(+12%)
Holding
1,698
Top Buys
| 1 | +$316M | |
| 2 | +$222M | |
| 3 | +$152M | |
| 4 |
Insmed
INSM
|
+$149M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$126M |
Top Sells
| 1 | +$1.68B | |
| 2 | +$683M | |
| 3 | +$229M | |
| 4 |
Costco
COST
|
+$188M |
| 5 |
PepsiCo
PEP
|
+$136M |
Sector Composition
| 1 | Healthcare | 16.82% |
| 2 | Technology | 13.21% |
| 3 | Financials | 11.22% |
| 4 | Industrials | 6.79% |
| 5 | Consumer Discretionary | 6.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
326
Zevia
ZVIA
$93.1M
| $4.86M | 0.04% |
+2,096,590
|
|
||
327
APA Corp
APA
$11.6B
| $4.82M | 0.04% |
197,017
+122,158
|
|
||
328
Philip Morris
PM
$265B
| $4.79M | 0.04% |
29,875
-40,924
|
|
||
329
American Express
AXP
$207B
| $4.78M | 0.04% |
12,922
-22,408
|
|
||
|
B
330
Barrick Mining
B
$76.1B
| $4.74M | 0.04% |
108,838
-23,316
|
|
||
331
Halliburton
HAL
$28.5B
| $4.73M | 0.04% |
167,526
+114,526
|
|
||
332
Nektar Therapeutics
NKTR
$1.98B
| $4.73M | 0.04% |
111,900
-191,300
|
|
||
333
Wells Fargo
WFC
$248B
| $4.72M | 0.04% |
50,628
-30,271
|
|
||
334
Phillips 66
PSX
$66.5B
| $4.7M | 0.04% |
+36,458
|
|
||
335
Goldman Sachs
GS
$244B
| $4.69M | 0.04% |
5,332
+3,699
|
|
||
336
Labcorp
LH
$22.2B
| $4.67M | 0.04% |
18,624
+12,824
|
|
||
337
Invesco DB US Dollar Index Bearish Fund
UDN
$146M
| $4.67M | 0.04% |
255,811
-10,133
|
|
||
338
Adobe
ADBE
$116B
| $4.64M | 0.04% |
13,268
+10,338
|
|
||
339
Jack Henry & Associates
JKHY
$12.4B
| $4.63M | 0.04% |
+25,378
|
|
||
340
Nordson
NDSN
$15.2B
| $4.63M | 0.04% |
+19,241
|
|
||
341
Acuity Brands
AYI
$8.45B
| $4.62M | 0.04% |
12,819
+10,496
|
|
||
342
Enova International
ENVA
$3.44B
| $4.61M | 0.04% |
+29,327
|
|
||
343
Fulton Financial
FULT
$3.63B
| $4.58M | 0.04% |
+236,951
|
|
||
344
KeyCorp
KEY
$21.6B
| $4.55M | 0.04% |
220,523
+84,497
|
|
||
345
Regeneron Pharmaceuticals
REGN
$80.3B
| $4.54M | 0.04% |
5,885
-19,650
|
|
||
346
Rocket Companies
RKT
$42.1B
| $4.47M | 0.04% |
231,108
+208,150
|
|
||
347
United Therapeutics
UTHR
$21B
| $4.46M | 0.04% |
+9,149
|
|
||
348
Palo Alto Networks
PANW
$135B
| $4.46M | 0.04% |
24,195
+19,112
|
|
||
349
Pacira BioSciences
PCRX
$891M
| $4.45M | 0.04% |
172,092
+123,805
|
|
||
350
Archer Daniels Midland
ADM
$32.5B
| $4.43M | 0.04% |
+77,143
|
|